Analyst Ratings February 4, 2026

Benchmark Lifts TAT Technologies Target to $58 After Investor Day; Buy Rating Unchanged

Analyst cites accelerating revenue, expanding backlog and upcoming APU MRO awards and M&A as drivers for premium valuation

By Nina Shah TATT
Benchmark Lifts TAT Technologies Target to $58 After Investor Day; Buy Rating Unchanged
TATT

Benchmark raised its price objective on TAT Technologies (NASDAQ: TATT) from $53 to $58 while keeping a Buy rating, noting management's Investor Day presentation and several near-term catalysts. The new target implies roughly 24% upside from the current share price of $46.76. Recent multi-year and one-year revenue growth, alongside a growing backlog and shareholder approvals, underpin the broker's view.

Key Points

  • Benchmark raised its price target on TAT Technologies to $58 from $53 and maintained a Buy rating - impacts equity investors and aerospace parts suppliers.
  • The new target implies approximately 24% upside from the current share price of $46.76; TATT is up 61.6% over the past year - relevant for market participants monitoring momentum.
  • Catalysts cited include potential APU MRO awards and M&A activity, supported by recent revenue acceleration (20.7% year-over-year) and a 5-year revenue CAGR of 9% - affects aerospace maintenance and aftermarket services sectors.

Benchmark increased its price target on TAT Technologies (NASDAQ: TATT) to $58.00 from $53.00 on Wednesday and maintained a Buy recommendation on the shares. At the time of Benchmark's revision, the $58 target implied roughly 24% upside relative to the prevailing market price of $46.76.

The upgrade to the target followed TAT Technologies' recent Investor Day, where management laid out a growth agenda that Benchmark characterized as "ambitious and very doable." The research house pointed to company metrics showing accelerated top-line performance as supportive evidence: 20.7% revenue growth over the last twelve months and a five-year compound annual growth rate (CAGR) in revenue of 9%, according to InvestingPro data cited by Benchmark.

Benchmark flagged several drivers behind its decision to raise the target. The firm highlighted "major catalysts looming via needle-moving APU MRO awards and M&A activity" that it expects could materially influence future results. Additionally, the analyst team identified scope for "long-term margin expansion" that surpasses its prior assumptions, contributing to a premium valuation for the stock.

In its note, Benchmark justified applying a richer multiple to TAT based on a combination of factors: sustained double-digit revenue growth, an expanding backlog, and the pipeline of potential catalysts. Those elements together formed the basis for the firm's higher target.

Other recent developments reinforce market attention on the company. Lake Street Capital Markets initiated coverage on TAT Technologies with a Buy rating and a price target set at $53, a view published by analyst Jaeson Schmidt. Separately, TAT reported that shareholders approved all proposals presented at its Annual and Special General Meeting held in Tel Aviv. The company said that items in the proxy statement previously submitted to the Securities and Exchange Commission received the necessary approvals under Israeli Companies Law; the approvals were recorded at the offices of Naschitz, Brandes, Amir & Co., Advocates.

Collectively, the Investor Day presentation, analyst coverage moves, and corporate governance approvals point to a period of strategic alignment and investor interest for the company.

A Fair Value calculator is referenced as a rapid means to assess whether TATT is attractively priced, noting that the tool uses a mix of 17 industry valuation models to produce a valuation view for the stock and thousands of other names.


Bottom line - Benchmark's target raise to $58 reflects confidence in TAT Technologies' growth trajectory and upcoming catalysts, while other analyst activity and shareholder approvals have added to the positive market backdrop.

Risks

  • Anticipated catalysts such as APU MRO awards and M&A activity may not materialize or may have limited impact - this creates execution risk for valuation improvements, affecting aerospace and specialty finance investors.
  • Margin expansion expected by analysts may fall short of projections, limiting the case for a premium multiple - operational and profitability risk impacting investor returns.
  • Reliance on backlog growth and upcoming awards introduces timing risk; delays could temper near-term stock performance and investor sentiment in the aerospace parts and services market.

More from Analyst Ratings

UBS trims TransDigm price target slightly to $1,800, keeps Buy as aftermarket growth cools Feb 4, 2026 UBS Holds Neutral on Electronic Arts as Battlefield 6 Boosts Quarterly Results Feb 4, 2026 UBS Raises DaVita Target to $190, Cites Elevated 2026 EPS Outlook Feb 4, 2026 UBS Boosts FedEx Price Target to $412, Cites Pricing Levers and Cost Cuts Feb 4, 2026 DA Davidson Lifts Almonty Industries Price Target to $18 as Tungsten Dynamics Shift Feb 4, 2026